top of page

Holistic care for neurological diseases

MyaLink was developed by a team of experts consisting of clinical and research neurologists together with a technology partner and patients. All neurologists have many years of experience and extensive specialist knowledge when it comes to the treatment of neurological diseases works. 

Team myalink Lehnerer.jpg

Dr. med. Sophie Lehnerer

Medicine & Business

Sophie Lehnerer studied human medicine and healthcare management and has been a neurology specialist since 2020. During her training, she studied and worked in Munich, NYC, Italy, Ireland and Switzerland, among others, and has been working at the Charité Universitätsmedizin Berlin since 2015. Dr. works there. Lehnerer focuses on the iMZ (integrated myasthenia center) and conducts research in the area of burden of disease and the development of digital tools to improve care for myasthenia patients. She is a fellow of the BIH Digital Clinician Scientist and SPARK program. In addition to numerous scientific publications, she won prizes such as the Health-i Award 2021 and the Patient Stakeholder Award. Stein.jpg

Dr. Maike Stein studied human medicine and worked and studied during her training in various cities, including Boston, Munich, Dubai and Zurich, as well as at the United Nations headquarters in New York City. She has been working at the Charité Universitätsmedizin Berlin and in the Integrated Myasthenia Center (iMZ) since 2019. Dr. Stein conducts research at the Charité Berlin and at Harvard University in Boston. Her research work focuses on developing and improving patient care through digital tools for myasthenia gravis as well as identifying digital biomarkers to predict myasthenic crises. Dr. Stein was also a fellow in the BIH Digital Health Accelerator program and the NeuroCure/SPARK program. She also received funding for her commitment in the area of patient and stakeholder engagement, which is characterized by the active involvement of patients in research. In addition to her scientific publications, Dr. Stein has given numerous lectures and podcasts on the subject of MG and has been honored with awards such as the Health-i Award 2021 from Handelsblatt/Techniker Krankenkasse.

Dr. med. Maike Stein

Medicine & Science

Logo Qurasoft


Tech partner 

Qurasoft is the leading provider of remote patient monitoring for chronic diseases and has developed and implemented groundbreaking digital projects. The adaptable and scalable SaniQ platform is used for numerous medical use cases. Thanks to its high level of expertise in the technical and regulatory areas, Qurasoft is an innovative partner for doctors and researchers in the field of digital medicine. Gerischer.jpg

Dr. med. Lea Gerischer

Regulatory & study

Dr. Lea Gerischer studied human medicine and during her training studied and worked in India, Italy, England and Switzerland, among others. She has been working at the Charité Universitätsmedizin Berlin in the neurology clinic since 2013 and has been working primarily in the iMZ (integrated myasthenia center) since 2019. There she researches new drug therapies, the subjective patient perspective and the development of digital tools to improve patient care. Her research has been funded in the past by the Junior Clinician Scientist Program and the BIH Digital Health Accelerator Program. Andreas Meisel

Prof. Dr. med. Andreas Meisel

iMZ management & Science

Prof. Andreas Meisel is Professor of Neurology and Senior Physician at the Department of Neurology with Experimental Neurology and Neuroscience Clinical Research Center. He is the head of the Integrated Myasthenia Gravis Center and serves as director of the Centre for Stroke Research Berlin at the Charité Universitätsmedizin Berlin, Germany. He studied medicine at the Humboldt University Berlin and was EMBO fellow at the Biocenter, University of Basel, Switzerland. His group is active in the field of experimental and clinical research focussed in targeting immunity in neuromuscular junction disorders and stroke, establishing biomarker-based individualized decision making and developing comprehensive care approaches for these disorders.

Logo German Myasthenia Society e.V.

German Myasthenia Society e.V.

Patient organization

The German Myasthenia Society e. V. was founded in 1986 by those affected and is Europe's largest myasthenia self-help organization with around 3,400 members. The DMG provides information about the rare chronic diseases myasthenia gravis, Lambert-Eaton myasthenes syndrome and congenital myasthenia syndromes and is a contact point for those affected and their relatives as well as doctors and therapists. The association has a lot of information material for those affected, doctors and therapists and carries out intensive public relations and educational work to draw attention to myasthenic syndromes. A medical advisory board, which includes highly qualified scientists and doctors, supports the DMG in its work. Since 2010, the DMG has been certifying integrated myasthenia centers (iMZ) in order to continuously promote the quality and nationwide medical care of those affected with myasthenic syndromes. There are now 17 myasthenia centers. The data from the nationwide myasthenia registry is intended to help standardize routine care and thus improve the care situation for patients in the long term. Especially when it comes to rare diseases, it is important to pull together in order to make a difference. Networks for more knowledge and better care are important. As part of this network, we want to support the path through therapy, dealing with the disease and coping in everyday life. Drawing attention to needs and providing information can only be done together.

bottom of page